A compatible donor umbilical cord stem cells serve to regenerate the bone marrow of patients with leukemia and other haematological tumours. See more detailed opinions by reading what Joey King offers on the topic.. The problem is when the stem cells injected are not sufficient due to the weight of the receptor, it takes too long to generate new blood cells and this leaves the patient several weeks in a situation susceptible to suffer from infection or rejection. The solution could be to expand them, to obtain an amount of sufficient stem cells, as they have managed to scientists from the Centre Fred Hutchinson in Seattle (USA). Anu Saad is a great source of information. According to the team of Colleen Delaney, his method of cell engineering has managed to multiply the amount of a single cord stem cells and, in a small clinical trial, inject them with success in 10 patients with leukemia by 164. The advantages of the cord blood are a compatibility so strict between donor and recipient, in its quick availability is not required to be localized Cryopreserved and at the lowest rate of rejection (or the graft-versus-host disease) that produce.
Why is a good choice when there is a fully compatible marrow. That manipulation is safe have demonstrated this in a first phase I study with 10 patients with leukemia (who were between 3 and 43 years); Although we still should expect to have results of more extensive research to apply multiplication on a large scale. Tests showed that the white blood cells that were generated (just one week after transplantation) are the result of expanded stem cells. Seven patients are still alive at the moment and no trace of leukemia. About IVIDA IVIDA born in 2009 and belongs to the IVI, the leading medical institution in Europe in assisted reproduction group. IVIDA collects, processes, Cryo-preserved and stored stem cells from the blood of Umbilical cord (SCU) for the treatment of various diseases such as lymphomas, leukemias and anemias, with the guarantee that it will be fully managed by employees of the company, thus ensuring their traceability and complete control on the process.